title: Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide.
abstract: We have previously reported the antimetastatic effect of a single low-dose of cyclophosphamide (Cy) on L-TACB rat lymphoma. The phenomenon could be adoptively transferred in immunocompetent rats and is abolished in nude mice, facts for which an immunomodulatory explanation was proposed. The aim of this paper was to identify the mechanism(s) by which spleen cells from Cy-treated tumour-bearing rats could exert this antimetastatic activity. Conditioned media obtained by incubation of spleen cells from Cy-treated and non-treated tumour-bearing rats, under specific or non-specific stimulation, were assayed to evaluate their effect on lymphocyte proliferation. The production of transforming growth factor beta (TGF-beta), interleukin-10 (IL-10) and nitric oxide (NO) by conditioned media was also studied. The restoration of spleen lymphoproliferative responses to normal levels when exposed to media conditioned by splenocytes from Cy-treated tumour-bearing rats, together with a decreased production of suppressive cytokines TGF-beta, IL-10 and NO, suggest an enhancement of host antimetastatic immunity triggered by single low-dose Cy treatment.
authors.affiliation: Instituto de Genética Experimental, Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Argentina.
authors.forename: P
authors.initials: P
authors.lastname: Matar
authors.forename: V R
authors.initials: VR
authors.lastname: Rozados
authors.forename: A D
authors.initials: AD
authors.lastname: González
authors.forename: D G
authors.initials: DG
authors.lastname: Dlugovitzky
authors.forename: R D
authors.initials: RD
authors.lastname: Bonfil
authors.forename: O G
authors.initials: OG
authors.lastname: Scharovsky
mesh_terms: D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D002455:Cell Division; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016753:Interleukin-10 / Q000032:analysis; D008223:Lymphoma / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D009362:Neoplasm Metastasis / Q000473:pathology / Q000517:prevention & control*; D009573:Nitrites / Q000032:analysis; D051381:Rats; D016211:Transforming Growth Factor alpha / Q000032:analysis
chemical_list: D018906:Antineoplastic Agents, Alkylating; D007166:Immunosuppressive Agents; D009573:Nitrites; D016211:Transforming Growth Factor alpha; D016753:Interleukin-10; D003520:Cyclophosphamide